Telomere Length and Human Telomerase Reverse Transcriptase Expression As Markers for Progression and Prognosis of Colorectal Carcinoma

Maintenance of telomeres through reactivation of telomerase is a prerequisite for tumors to preserve their ability to proliferate. The purpose of this study was to evaluate telomere length and human telomerase reverse transcriptase (hTERT) expression as markers for progression and prognosis of color...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 22; no. 10; pp. 1807 - 1814
Main Authors GERTLER, Ralf, ROSENBERG, Robert, STRICKER, Dominik, FRIEDERICHS, Jan, HOOS, Axel, WERNER, Martin, ULM, Kurt, HOLZMANN, Bernhard, NEKARDA, Hjalmar, SIEWERT, Joerg-Ruediger
Format Journal Article
LanguageEnglish
Published Baltimore, MD American Society of Clinical Oncology 15.05.2004
Lippincott Williams & Wilkins
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Maintenance of telomeres through reactivation of telomerase is a prerequisite for tumors to preserve their ability to proliferate. The purpose of this study was to evaluate telomere length and human telomerase reverse transcriptase (hTERT) expression as markers for progression and prognosis of colorectal carcinoma. Telomere length and hTERT expression were analyzed in matched cancer and adjacent noncancer mucosa samples from 57 patients with R0-resected colorectal carcinoma. The median follow-up time was 76 months. Telomere length and hTERT expression correlated significantly in cancer tissues and adjacent mucosa samples (r = 0.52, P <.001; and r = 0.54, P <.001, respectively). Overall, cancer tissue had shorter telomeres than adjacent mucosa (P <.001). Only in noncancer tissue did telomere length decrease with age (r = 0.36; P <.01). Telomere length in cancer tissue was significantly correlated with tumor stage (P <.01), with longer telomeres in advanced tumors. Patients with ratios of telomere length in cancer to noncancer tissue greater than 0.90 had a significantly poorer overall survival compared with patients with smaller telomere length ratios (P <.002). In multivariate analysis, the telomere length ratio proved to be of independent prognostic value (P <.03). Telomeres in colorectal carcinoma tissue were significantly shorter compared with adjacent normal mucosa as an indication for extensive cell proliferation. The correlation with tumor stage and patient survival suggest that hTERT-mediated telomere stabilization may be critical for progression and prognosis of colorectal carcinoma.
AbstractList Purpose Maintenance of telomeres through reactivation of telomerase is a prerequisite for tumors to preserve their ability to proliferate. The purpose of this study was to evaluate telomere length and human telomerase reverse transcriptase (hTERT) expression as markers for progression and prognosis of colorectal carcinoma. Patients and Methods Telomere length and hTERT expression were analyzed in matched cancer and adjacent noncancer mucosa samples from 57 patients with R0-resected colorectal carcinoma. The median follow-up time was 76 months. Results Telomere length and hTERT expression correlated significantly in cancer tissues and adjacent mucosa samples (r = 0.52, P < .001; and r = 0.54, P < .001, respectively). Overall, cancer tissue had shorter telomeres than adjacent mucosa (P < .001). Only in noncancer tissue did telomere length decrease with age (r = 0.36; P < .01). Telomere length in cancer tissue was significantly correlated with tumor stage (P < .01), with longer telomeres in advanced tumors. Patients with ratios of telomere length in cancer to noncancer tissue greater than 0.90 had a significantly poorer overall survival compared with patients with smaller telomere length ratios (P < .002). In multivariate analysis, the telomere length ratio proved to be of independent prognostic value (P < .03). Conclusion Telomeres in colorectal carcinoma tissue were significantly shorter compared with adjacent normal mucosa as an indication for extensive cell proliferation. The correlation with tumor stage and patient survival suggest that hTERT-mediated telomere stabilization may be critical for progression and prognosis of colorectal carcinoma.
Maintenance of telomeres through reactivation of telomerase is a prerequisite for tumors to preserve their ability to proliferate. The purpose of this study was to evaluate telomere length and human telomerase reverse transcriptase (hTERT) expression as markers for progression and prognosis of colorectal carcinoma. Telomere length and hTERT expression were analyzed in matched cancer and adjacent noncancer mucosa samples from 57 patients with R0-resected colorectal carcinoma. The median follow-up time was 76 months. Telomere length and hTERT expression correlated significantly in cancer tissues and adjacent mucosa samples (r = 0.52, P <.001; and r = 0.54, P <.001, respectively). Overall, cancer tissue had shorter telomeres than adjacent mucosa (P <.001). Only in noncancer tissue did telomere length decrease with age (r = 0.36; P <.01). Telomere length in cancer tissue was significantly correlated with tumor stage (P <.01), with longer telomeres in advanced tumors. Patients with ratios of telomere length in cancer to noncancer tissue greater than 0.90 had a significantly poorer overall survival compared with patients with smaller telomere length ratios (P <.002). In multivariate analysis, the telomere length ratio proved to be of independent prognostic value (P <.03). Telomeres in colorectal carcinoma tissue were significantly shorter compared with adjacent normal mucosa as an indication for extensive cell proliferation. The correlation with tumor stage and patient survival suggest that hTERT-mediated telomere stabilization may be critical for progression and prognosis of colorectal carcinoma.
PURPOSEMaintenance of telomeres through reactivation of telomerase is a prerequisite for tumors to preserve their ability to proliferate. The purpose of this study was to evaluate telomere length and human telomerase reverse transcriptase (hTERT) expression as markers for progression and prognosis of colorectal carcinoma.PATIENTS AND METHODSTelomere length and hTERT expression were analyzed in matched cancer and adjacent noncancer mucosa samples from 57 patients with R0-resected colorectal carcinoma. The median follow-up time was 76 months.RESULTSTelomere length and hTERT expression correlated significantly in cancer tissues and adjacent mucosa samples (r = 0.52, P <.001; and r = 0.54, P <.001, respectively). Overall, cancer tissue had shorter telomeres than adjacent mucosa (P <.001). Only in noncancer tissue did telomere length decrease with age (r = 0.36; P <.01). Telomere length in cancer tissue was significantly correlated with tumor stage (P <.01), with longer telomeres in advanced tumors. Patients with ratios of telomere length in cancer to noncancer tissue greater than 0.90 had a significantly poorer overall survival compared with patients with smaller telomere length ratios (P <.002). In multivariate analysis, the telomere length ratio proved to be of independent prognostic value (P <.03).CONCLUSIONTelomeres in colorectal carcinoma tissue were significantly shorter compared with adjacent normal mucosa as an indication for extensive cell proliferation. The correlation with tumor stage and patient survival suggest that hTERT-mediated telomere stabilization may be critical for progression and prognosis of colorectal carcinoma.
Author Dominik Stricker
Martin Werner
Hjalmar Nekarda
Ralf Gertler
Robert Rosenberg
Joerg-Ruediger Siewert
Jan Friederichs
Bernhard Holzmann
Axel Hoos
Kurt Ulm
Author_xml – sequence: 1
  givenname: Ralf
  surname: GERTLER
  fullname: GERTLER, Ralf
  organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
– sequence: 2
  givenname: Robert
  surname: ROSENBERG
  fullname: ROSENBERG, Robert
  organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
– sequence: 3
  givenname: Dominik
  surname: STRICKER
  fullname: STRICKER, Dominik
  organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
– sequence: 4
  givenname: Jan
  surname: FRIEDERICHS
  fullname: FRIEDERICHS, Jan
  organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
– sequence: 5
  givenname: Axel
  surname: HOOS
  fullname: HOOS, Axel
  organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
– sequence: 6
  givenname: Martin
  surname: WERNER
  fullname: WERNER, Martin
  organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
– sequence: 7
  givenname: Kurt
  surname: ULM
  fullname: ULM, Kurt
  organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
– sequence: 8
  givenname: Bernhard
  surname: HOLZMANN
  fullname: HOLZMANN, Bernhard
  organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
– sequence: 9
  givenname: Hjalmar
  surname: NEKARDA
  fullname: NEKARDA, Hjalmar
  organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
– sequence: 10
  givenname: Joerg-Ruediger
  surname: SIEWERT
  fullname: SIEWERT, Joerg-Ruediger
  organization: Chirurgische Klinik und Poliklinik, Institut für Pathologie und Pathologische Anatomie, and Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15764676$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/15143073$$D View this record in MEDLINE/PubMed
BookMark eNpNkEtv1DAYRS1URKeFNTvkDbDK1I_ETpZVVChoUBEaJHaW43yecUnsqZ3h8Qf43ThMEKyu7Ht8ZZ0LdOaDB4SeU7KmjJCr9-3dOme5Js2aCvIIrWjFZCFlVZ2hFZGcFbTmX87RRUr3hNCy5tUTdE4rWvLcrtCvLQxhhAh4A3437bH2Pb49jtrjpdEJ8Cf4BjHnNmqfTHSHab69-XGIkJILHl8n_EHHrxnCNkT8MYbd32oenM8-JJdwsLgNQ4hgJj3gVkfjfBj1U_TY6iHBsyUv0ec3N9v2ttjcvX3XXm8KwxsxFWXFNDBOytKympGuIYRbIfvegu0Yp6IiwlogVvSNpp1lTSOhZ0SA7EpmJL9Er067hxgejpAmNbpkYBi0h3BMStKGl7SpM3h1Ak0MKUWw6hDdqONPRYma1ausXs3qFWlUVp9fvFimj90I_T9-cZ2Blwugk9GDzS6NS_9xUpRCisy9PnF7t9t_dxFUGvUw5Fmm7k1g7M8X6jz5G7M6nQY
CitedBy_id crossref_primary_10_1007_s11684_016_0450_2
crossref_primary_10_1007_s12094_016_1559_0
crossref_primary_10_1002_cncr_23419
crossref_primary_10_1089_gtmb_2015_0150
crossref_primary_10_1016_j_prp_2010_05_009
crossref_primary_10_1016_j_cancergen_2019_07_007
crossref_primary_10_3892_ol_2017_6284
crossref_primary_10_1038_bjc_2014_561
crossref_primary_10_1002_hon_937
crossref_primary_10_1002_jso_23894
crossref_primary_10_1515_CCLM_2010_049
crossref_primary_10_1111_j_1745_7254_2007_00488_x
crossref_primary_10_3390_cancers14092250
crossref_primary_10_1016_j_bbamcr_2019_07_001
crossref_primary_10_1038_sj_leu_2404141
crossref_primary_10_1200_JCO_2005_04_2127
crossref_primary_10_3390_cancers15041159
crossref_primary_10_1093_jnci_djt191
crossref_primary_10_1158_1078_0432_CCR_18_0630
crossref_primary_10_1007_s12032_010_9506_3
crossref_primary_10_4155_bio_12_203
crossref_primary_10_1016_j_tranon_2019_05_010
crossref_primary_10_1111_j_1349_7006_2010_01782_x
crossref_primary_10_1586_era_12_3
crossref_primary_10_7314_APJCP_2012_13_2_443
crossref_primary_10_1002_ijc_23376
crossref_primary_10_1186_s12885_016_2997_3
crossref_primary_10_1371_journal_pone_0107268
crossref_primary_10_1038_onc_2013_446
crossref_primary_10_1016_j_jgo_2013_09_001
crossref_primary_10_1177_1099800413519495
crossref_primary_10_18632_oncotarget_9015
crossref_primary_10_1097_01_ju_0000143195_49685_ce
crossref_primary_10_4251_wjgo_v1_i1_3
crossref_primary_10_1371_journal_pone_0149626
crossref_primary_10_1007_s40291_018_0336_x
crossref_primary_10_1007_s12094_011_0673_2
crossref_primary_10_1111_j_1463_1318_2010_02433_x
crossref_primary_10_1093_carcin_bgr053
crossref_primary_10_1126_sciadv_add8023
crossref_primary_10_18632_oncotarget_5968
crossref_primary_10_1158_1078_0432_CCR_10_3271
crossref_primary_10_1155_2012_598984
crossref_primary_10_1016_j_ejca_2004_11_024
crossref_primary_10_18632_oncotarget_20055
crossref_primary_10_1182_blood_2007_05_092759
crossref_primary_10_1016_j_prp_2016_11_010
crossref_primary_10_1152_physrev_00020_2018
crossref_primary_10_1586_17474124_2013_848790
crossref_primary_10_1172_JCI86042
crossref_primary_10_1042_bse0480147
crossref_primary_10_1158_0008_5472_CAN_08_3513
crossref_primary_10_12688_f1000research_19091_1
crossref_primary_10_1002_cncr_21625
crossref_primary_10_3389_fonc_2015_00296
crossref_primary_10_1111_j_1442_2042_2006_01300_x
crossref_primary_10_1016_j_jgo_2021_12_008
crossref_primary_10_1002_iub_1758
crossref_primary_10_1017_S146239941000147X
crossref_primary_10_18632_oncotarget_9796
crossref_primary_10_3389_fonc_2019_01172
crossref_primary_10_1371_journal_pone_0064296
crossref_primary_10_1002_ijc_31978
crossref_primary_10_1172_JCI43452
crossref_primary_10_1016_j_bbadis_2009_02_006
crossref_primary_10_1016_j_febslet_2005_04_021
crossref_primary_10_18632_oncotarget_1829
crossref_primary_10_1007_s11033_008_9295_3
crossref_primary_10_1038_s41416_019_0525_3
crossref_primary_10_1590_1414_431x20176019
crossref_primary_10_1007_s12032_011_9866_3
crossref_primary_10_1016_j_yexmp_2017_05_010
crossref_primary_10_3390_ijms18091871
crossref_primary_10_1093_bib_bby020
crossref_primary_10_1038_labinvest_3700710
crossref_primary_10_1038_s41419_022_04885_8
crossref_primary_10_18632_genesandcancer_140
crossref_primary_10_1007_s00401_015_1432_1
crossref_primary_10_1097_PPO_0000000000000665
crossref_primary_10_1016_j_ctrv_2016_08_007
crossref_primary_10_1080_00313020600580468
crossref_primary_10_1016_S1470_2045_13_70110_4
crossref_primary_10_1007_s13277_015_3545_5
crossref_primary_10_3945_jn_109_104984
crossref_primary_10_1002_mc_22567
crossref_primary_10_1007_s11888_009_0028_3
crossref_primary_10_1038_s41597_024_03562_z
crossref_primary_10_1038_modpathol_3800504
crossref_primary_10_1038_onc_2012_441
crossref_primary_10_1002_ijc_22120
crossref_primary_10_1371_journal_pone_0133174
crossref_primary_10_1158_1078_0432_CCR_08_0478
crossref_primary_10_1111_bjh_14244
crossref_primary_10_1093_annonc_mdn394
crossref_primary_10_1016_S1470_2045_08_70234_1
crossref_primary_10_1016_j_humpath_2006_08_019
crossref_primary_10_1371_journal_pone_0109921
crossref_primary_10_3389_fmolb_2022_1100285
crossref_primary_10_1016_j_ajpath_2011_05_056
crossref_primary_10_1177_117727190700200030
crossref_primary_10_1002_cncr_22132
crossref_primary_10_3390_medicina56090463
crossref_primary_10_1111_j_1582_4934_2011_01284_x
crossref_primary_10_1016_j_saa_2018_02_024
crossref_primary_10_1016_j_molmed_2012_11_006
crossref_primary_10_1053_j_gastro_2009_12_065
crossref_primary_10_4236_jct_2014_513118
crossref_primary_10_1007_s12032_010_9444_0
crossref_primary_10_3892_br_2015_444
crossref_primary_10_1593_neo_07106
crossref_primary_10_1111_bjh_13023
crossref_primary_10_1080_14737159_2017_1337511
crossref_primary_10_1089_gtmb_2013_0436
crossref_primary_10_1016_j_tjog_2019_11_007
crossref_primary_10_1016_j_febslet_2011_07_005
crossref_primary_10_1038_bjc_2012_602
crossref_primary_10_1593_neo_05715
crossref_primary_10_1158_1055_9965_EPI_05_0542
crossref_primary_10_1016_j_ejca_2009_07_008
crossref_primary_10_1016_j_ejphar_2017_05_039
crossref_primary_10_18632_oncotarget_339
crossref_primary_10_1016_S0140_6736_05_17706_X
crossref_primary_10_3748_wjg_v22_i25_5678
crossref_primary_10_1038_sj_bjc_6605644
crossref_primary_10_1158_1055_9965_EPI_09_0360
crossref_primary_10_1016_j_bbadis_2009_01_017
crossref_primary_10_1016_j_jhep_2013_05_011
crossref_primary_10_1016_j_oraloncology_2015_02_100
crossref_primary_10_3390_ijms23020852
crossref_primary_10_1515_CCLM_2007_133
Cites_doi 10.1200/JCO.2000.18.13.2582
10.1126/science.7605428
10.1002/cncr.10939
10.1002/(SICI)1098-2744(199912)26:4<312::AID-MC10>3.0.CO;2-A
10.1093/clinchem/46.3.313
10.1073/pnas.96.7.3339
10.1038/346866a0
10.1038/sj.neo.7900112
10.1038/22780
10.1080/01621459.1958.10501452
10.1016/0092-8674(89)90035-4
10.1007/s004320050294
10.1038/sj.neo.7900113
10.1055/s-2007-1024277
10.1016/S0304-3835(00)00521-8
10.1111/j.2517-6161.1972.tb00899.x
10.1038/ng1297-498
10.1038/ng0198-65
10.1038/13495
10.1002/(SICI)1097-0142(19991015)86:8<1431::AID-CNCR7>3.0.CO;2-R
10.3892/ijo.16.6.1173
10.1002/j.1460-2075.1992.tb05245.x
10.1056/NEJMra021902
10.1038/sj.onc.1202458
10.1126/science.279.5349.349
10.1111/j.1572-0241.2001.03890.x
10.1038/554
10.1002/1097-0215(200002)9999:9999<::AID-IJC1103>3.0.CO;2-V
10.1038/350569a0
ContentType Journal Article
Copyright 2004 INIST-CNRS
Copyright_xml – notice: 2004 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1200/JCO.2004.09.160
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1527-7755
EndPage 1814
ExternalDocumentID 10_1200_JCO_2004_09_160
15143073
15764676
jco22_10_1807
Genre Evaluation Studies
Journal Article
GeographicLocations Germany
GeographicLocations_xml – name: Germany
GroupedDBID -
0R
2WC
34G
39C
3O-
4.4
53G
55
5GY
5RE
8F7
8WZ
A6W
AAPEM
AARDX
AAWTL
AAYEP
ABFLS
ABOCM
ACDCL
ACGFS
ADBBV
ADBIT
ADKWQ
AENEX
AFFNX
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AWKKM
AZFZN
BAWUL
CS3
DIK
EBS
EJD
F5P
FD8
FH7
GJ
GX1
H13
HZ
IH2
K-O
KQ8
L7B
LSO
N9A
NTWIH
O9-
OK1
OVD
OWW
P2P
RHI
RUC
SJN
SV3
TWZ
UDS
VH1
WH7
X7M
YCJ
ZA5
ZGI
---
.55
.GJ
08G
08P
08R
0R~
18M
29K
5VS
AAKAS
AAQQT
AAUGY
AAYOK
ACGFO
ADZCM
AEGXH
AI.
AIAGR
C45
D-I
EX3
F9R
FBNNL
FEDTE
HZ~
IPNFZ
IQODW
J5H
MJL
N4W
QTD
R1G
RIG
RLZ
TEORI
TR2
UHU
VVN
WOQ
WOW
YFH
YQY
ABJNI
ACGUR
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c396t-452ae23044f2820b9003f67ddfefb2316506ffe0f6d9a1bf2997ed206e7b42c73
ISSN 0732-183X
IngestDate Fri Oct 25 04:01:10 EDT 2024
Fri Aug 23 03:02:04 EDT 2024
Sat Sep 28 07:41:32 EDT 2024
Sun Oct 22 16:05:47 EDT 2023
Tue Jan 05 20:17:21 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Human
Rectal disease
Prognosis
RNA-directed DNA polymerase
Enzyme
Transferases
Colorectal cancer
Biological marker
Reverse transcription
Malignant tumor
Telomere
Colonic disease
Nucleotidyltransferases
Digestive diseases
Intestinal disease
Telomerase
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c396t-452ae23044f2820b9003f67ddfefb2316506ffe0f6d9a1bf2997ed206e7b42c73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.09.160?role=tab
PMID 15143073
PQID 71934198
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_71934198
crossref_primary_10_1200_JCO_2004_09_160
pubmed_primary_15143073
pascalfrancis_primary_15764676
highwire_smallpub2_jco22_10_1807
ProviderPackageCode RHI
PublicationCentury 2000
PublicationDate 2004-05-15
PublicationDateYYYYMMDD 2004-05-15
PublicationDate_xml – month: 05
  year: 2004
  text: 2004-05-15
  day: 15
PublicationDecade 2000
PublicationPlace Baltimore, MD
PublicationPlace_xml – name: Baltimore, MD
– name: United States
PublicationTitle Journal of clinical oncology
PublicationTitleAlternate J Clin Oncol
PublicationYear 2004
Publisher American Society of Clinical Oncology
Lippincott Williams & Wilkins
Publisher_xml – name: American Society of Clinical Oncology
– name: Lippincott Williams & Wilkins
References R21
R20
R23
R22
R25
R24
R27
R26
R29
R28
R1
R2
R3
R4
R5
R6
R7
R8
R9
R30
R10
R32
R31
R12
R34
R11
R33
R14
R13
R35
R16
R15
R18
R17
R19
References_xml – ident: R30
  doi: 10.1200/JCO.2000.18.13.2582
– ident: R7
  doi: 10.1126/science.7605428
– ident: R17
  doi: 10.1002/cncr.10939
– ident: R24
  doi: 10.1002/(SICI)1098-2744(199912)26:4<312::AID-MC10>3.0.CO;2-A
– ident: R26
  doi: 10.1093/clinchem/46.3.313
– ident: R23
– ident: R5
  doi: 10.1073/pnas.96.7.3339
– ident: R2
  doi: 10.1038/346866a0
– ident: R34
  doi: 10.1038/sj.neo.7900112
– ident: R9
  doi: 10.1038/22780
– ident: R21
  doi: 10.1080/01621459.1958.10501452
– ident: R6
  doi: 10.1016/0092-8674(89)90035-4
– ident: R28
  doi: 10.1007/s004320050294
– ident: R35
  doi: 10.1038/sj.neo.7900113
– ident: R16
– ident: R4
  doi: 10.1055/s-2007-1024277
– ident: R18
– ident: R19
  doi: 10.1016/S0304-3835(00)00521-8
– ident: R31
– ident: R22
  doi: 10.1111/j.2517-6161.1972.tb00899.x
– ident: R11
  doi: 10.1038/ng1297-498
– ident: R14
– ident: R10
  doi: 10.1038/ng0198-65
– ident: R13
  doi: 10.1038/13495
– ident: R20
  doi: 10.1002/(SICI)1097-0142(19991015)86:8<1431::AID-CNCR7>3.0.CO;2-R
– ident: R32
  doi: 10.3892/ijo.16.6.1173
– ident: R3
  doi: 10.1002/j.1460-2075.1992.tb05245.x
– ident: R8
  doi: 10.1056/NEJMra021902
– ident: R25
  doi: 10.1038/sj.onc.1202458
– ident: R12
  doi: 10.1126/science.279.5349.349
– ident: R29
  doi: 10.1111/j.1572-0241.2001.03890.x
– ident: R15
– ident: R27
  doi: 10.1038/554
– ident: R33
  doi: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1103>3.0.CO;2-V
– ident: R1
  doi: 10.1038/350569a0
SSID ssj0014835
Score 2.2561269
Snippet Maintenance of telomeres through reactivation of telomerase is a prerequisite for tumors to preserve their ability to proliferate. The purpose of this study...
Purpose Maintenance of telomeres through reactivation of telomerase is a prerequisite for tumors to preserve their ability to proliferate. The purpose of this...
PURPOSEMaintenance of telomeres through reactivation of telomerase is a prerequisite for tumors to preserve their ability to proliferate. The purpose of this...
SourceID proquest
crossref
pubmed
pascalfrancis
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 1807
SubjectTerms Adult
Aged
Aged, 80 and over
Biological and medical sciences
Biomarkers, Tumor - biosynthesis
Biomarkers, Tumor - genetics
Blotting, Southern
Case-Control Studies
Colorectal Neoplasms - genetics
Colorectal Neoplasms - metabolism
Colorectal Neoplasms - mortality
Colorectal Neoplasms - pathology
Colorectal Neoplasms - surgery
DNA-Binding Proteins
Female
Gastroenterology. Liver. Pancreas. Abdomen
Gene Expression Regulation, Neoplastic
Germany
Humans
Male
Medical sciences
Middle Aged
Neoplasm Staging
Polymerase Chain Reaction
Predictive Value of Tests
Prognosis
Proportional Hazards Models
RNA, Messenger - analysis
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Survival Analysis
Telomerase - biosynthesis
Telomerase - genetics
Telomere - metabolism
Tumors
Title Telomere Length and Human Telomerase Reverse Transcriptase Expression As Markers for Progression and Prognosis of Colorectal Carcinoma
URI http://jco.ascopubs.org/content/22/10/1807.abstract
https://www.ncbi.nlm.nih.gov/pubmed/15143073
https://search.proquest.com/docview/71934198
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAvCMatXIYf0ITEAonrOskjtN06xtap66S-RU5iS6A2Qb1IjB_Ar-THcE7sXDqKuLxEVSI7rb6vx-fY53yHkJdCp1xqjztJ7CqHCwhQAjcNHU_yOAl9N0iLE93TMzG85B-m3Wmr9aORtbRexW-Sb1vrSv4HVbgHuGKV7D8gW00KN-Az4AtXQBiuf4exmuVztVCvsR2KrVEzTfdW5gksUVicAi6ewmYQmbEReFd9tRmwGXaamWOSzqKQZjAZW-WjQkUgx2Q8o1uCGtdoI1FVBLsQZbm167_6t1XNZZ4lG3v3R4Px5KNNwJAzXR35jC4GZ-8H46M64bva_pmMj3snZkg_RzWUqr7ocHw86GNW7PDCJP1mG_sYHI_gTSWn2cfYokdR7GN8mmGyUMMs-h3mgCGamhXMmm3mQ5xgBH9Lu85Yk79uw0p7gem0a1d8cHL41tWEmUbZvVGxj4B6uJ5pfrCp231tPa2yHD2I5WAdEjfITQZmEBMO-8cn1RkXD0z71_L3WOEpeNXba6_c9JlKHWtM45VLwFGbFiy_j5EKX2lyl9yxJKDvDGPvkZbKdsmtU5vGsUv2z41g-tUBndT1f8sDuk_Payn1q_vke8lwahhOgZC0YDitGU4tw-kGw2nNcCqX1DKcAsNpg-HFhBXDaa5pzXBaMfwBuTwcTHpDx3YOcZJOKFYO7zKp8LiDawYubozb9Vr4aaqVjiGigbBEaK1cLdJQerEGn8xXKXOF8mPOEr_zkOxkeaYeE8o9nXR0R3RlmPI05hLwUonQvvT8QIukTV6V2ERfjEBMhIE1w1Pi3gjbvPLIDSOAsU1oiV20nMvZDDBi0eckZ6wYAqxsk70NTOspLZfa5EUJcgQLAZ7uyUzl62XkQyjGvTBok0cG-8ZYCIrgaz_50-RPye36n_mM7KwWa_UcfO5VvFdQ9yf3Xd0j
link.rule.ids 315,783,787,27938,27939
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Telomere+length+and+human+telomerase+reverse+transcriptase+expression+as+markers+for+progression+and+prognosis+of+colorectal+carcinoma&rft.jtitle=Journal+of+clinical+oncology&rft.au=GERTLER%2C+Ralf&rft.au=ROSENBERG%2C+Robert&rft.au=STRICKER%2C+Dominik&rft.au=FRIEDERICHS%2C+Jan&rft.date=2004-05-15&rft.pub=Lippincott+Williams+%26+Wilkins&rft.issn=0732-183X&rft.eissn=1527-7755&rft.volume=22&rft.issue=10&rft.spage=1807&rft.epage=1814&rft_id=info:doi/10.1200%2FJCO.2004.09.160&rft.externalDBID=n%2Fa&rft.externalDocID=15764676
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0732-183X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0732-183X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0732-183X&client=summon